ACORN CAPITAL ADVISORS, LLC 13F Portfolio

EntityCategoryQoQ AUM ChangeAUM (13F)# of HoldingsPerformance RankEquities Trend
AC
ACORN CAPITAL ADVISORS, LLC
Institutional Filer 19.21%$351.8M22

Current Portfolio Holdings

Showing all 22 reported positions by value

#StockCompany NameSectorShares HeldMarket Value% of Portfolio
1TERNTerns Pharmaceuticals, Inc.Healthcare1.7M$92.1M26.17%
2CGONCG Oncology, Inc. Common stockHealthcare1.1M$76.6M21.77%
3URGNUroGen Pharma Ltd.Healthcare1.7M$30.1M8.55%
4PBYIPuma Biotechnology, Inc.Healthcare4.1M$26.4M7.50%
5TRVITrevi Therapeutics, Inc.Healthcare2.1M$25.6M7.27%
6CADLCandel Therapeutics, Inc.Healthcare3.5M$17.2M4.89%
7BCAXBicara Therapeutics Inc. Common StockHealthcare643K$12.8M3.64%
8OKUROnKure Therapeutics, Inc.Healthcare2.8M$11.8M3.34%
9JBIOJade Biosciences, Inc.Healthcare787K$11.1M3.14%
10TARAProtara Therapeutics, Inc.Healthcare1.8M$9.1M2.59%
11VSTMVerastem, Inc.Healthcare1.5M$7.8M2.21%
12HELPHELUS PHARMA INC.1.5M$7.4M2.10%
13LONALEONABIO, INC.635K$6.5M1.85%
14AURAAura Biosciences, Inc.Healthcare596K$4.0M1.13%
15WHWKWhitehawk Therapeutics IncHealthcare1.1M$3.9M1.12%
Showing 1 to 15 of 22 holdings
ACORN CAPITAL ADVISORS, LLC 13F Portfolio Holdings & Trades (Q1 2026) | VCP Scanner